Searched for
COPD PATIENTS
Can a cough reveal lung disease? Swaasa AI uses cough sound analysis to screen respiratory disordersAI-powered platform Swaasa is using cough sound analysis through smartphones to help screen respiratory diseases such as COPD, asthma and p...- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- Glenmark launches fixed-dose triple therapy for COPDGlenmark Pharmaceuticals has launched a groundbreaking nebulised triple therapy for COPD. This single, easy-to-use treatment combines three...
- AstraZeneca's asthma drug fails 'smoker's lung' studyAstraZeneca's Fasenra failed to reduce flare-ups in COPD patients in a late-stage trial, a setback for the company's efforts to address the...
- Why Smoker's Disease is rising among the millennials and Gen ZsA recent study reveals that COPD, or Smokers' Disease, is impacting younger individuals. Doctors in Delhi are observing a rise in cases amo...
- EU approves Sanofi's Dupixent for 'smoker's lungs'Sanofi and Regeneron received EU approval for broader use of Dupixent in treating chronic obstructive pulmonary disease (COPD), a significa...
- Cold & poor air leading to a surge in respiratory illness: DocsIncreasing cases of respiratory illnesses, including asthma, COPD, bronchitis, and pneumonia, are attributed to poor air quality and severe...
- UK charity warns Bonfire Night smoke may worsen conditions for asthma patients, urges extra precautionsPeople who suffer from asthma can get triggered by poor air quality, bonfire smoke, coupled with colder winds which further deteriorate the...
- What is the cost of diagnosis, treatment for pulmonary diseasesAny disease that affects lungs and parts of the respiratory system is known as pulmonary disease. Brought into the limelight by Covid, also...
- GSK launches once daily, single inhaler-triple therapy for COPD patientsTrelegy is delivered via the innovative Ellipta inhaler that provides accurate dosing through its consistent dose delivery mechanism and is...
- Zydus Pharmaceuticals (USA) Inc gets final US FDA approval to market Roflumilast tabletsRoflumilast tablets are indicated as a treatment to reduce the risk of COPD exacerbations in patients with severe COPD associated with chro...
- Cipla launches portable spirometer to diagnose COPD diseasesWith this launch, the company intends to revolutionize Obstructive Airway Disease (OAD) diagnosis, in line with its ambition to strengthen ...
- World COPD Day: Indoor air pollution an invisible evil; avoid incense sticks at home, have fibre-rich food & limit salt intakeCOPD causes more deaths annually than diabetes, malaria, TB and breast cancer combined.
- Zydus Cadila launches new product for COPD patients in IndiaDrug firm Zydus Cadila on Thursday said it is launching pressurized metered dose inhaler for patients suffering from Chronic Obstructive Pu...
- Smokers, those suffering from lung disease more likely to have health complications, face higher death risk due to Covid-19COPD is a common, persistent dysfunction of the lung associated with a limitation in airflow.
- Stub the cigarette: Smokers may be at higher risk of severe coronavirus infectionsPatients with COPD were at higher risk of having worse outcomes from COVID-19.
- AstraZeneca gets marketing nod for asthma drug SymbicortResults from AstraZeneca's two clinical studies have shown that the addition of formoterol to budesonide improved asthma symptoms and lung ...
- COPD may change brain structure: StudyCOPD is a lung disease that makes it hard to breathe and is caused by damage to the lungs from many years, usually from smoking.
- New method developed to produce 3D images of lungsThis method could lead to better treatment for chronic obstructive pulmonary disease (COPD) and lung cancer.
- Apollo, Lupin unveil country's first disease management planApollo Hospitals Group has joined hands with Lupin Limited to create the first Disease Management Programme (DMP) for Bronchial Asthma and ...
Load More
